Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H26N4O2.2C2H6O4S |
Molecular Weight | 606.709 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCS(O)(=O)=O.OCCS(O)(=O)=O.NC(=N)C1=CC=C(OCCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
InChI
InChIKey=NBVZMBLJRHUOJR-UHFFFAOYSA-N
InChI=1S/C20H26N4O2.2C2H6O4S/c21-19(22)15-5-9-17(10-6-15)25-13-3-1-2-4-14-26-18-11-7-16(8-12-18)20(23)24;2*3-1-2-7(4,5)6/h5-12H,1-4,13-14H2,(H3,21,22)(H3,23,24);2*3H,1-2H2,(H,4,5,6)
Molecular Formula | C2H6O4S |
Molecular Weight | 126.132 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C20H26N4O2 |
Molecular Weight | 354.446 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia. | 1990 Apr |
|
1,5-Bis(4-amidinophenoxy)pentane (pentamidine) is a potent inhibitor of [3H]idazoxan binding to imidazoline I2 binding sites. | 1998 Jul 17 |
|
Bilateral Acanthamoeba keratitis with late recurrence of the infection in a corneal graft: a case report. | 2003 Apr |
|
Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity. | 2003 Aug |
|
Systemic allergy to topical hexamidine. | 2006 Aug 7 |
|
A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents. | 2006 Jun |
|
[Clinical tolerance of cutaneous antiseptics in 3,403 patients in France]. | 2006 Oct |
|
[Towards new antibacterial drugs. Interest of para-guanidinoethylcalix[4]arene]. | 2006 Oct-Nov |
|
[Acanthamoeba keratitis: about the first two Tunisian cases]. | 2007 Feb |
|
In vitro activity of para-guanidinoethylcalix[4]arene against susceptible and antibiotic-resistant Gram-negative and Gram-positive bacteria. | 2007 Sep |
|
Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor. | 2007 Sep |
|
A new Sephadex-based method for removing microbicidal and cytotoxic residues when testing antiseptics against viruses: Experiments with a human coronavirus as a model. | 2009 Aug |
|
p-Guanidinoethyl calixarene and parent phenol derivatives exhibiting antibacterial activities. Synthesis and biological evaluation. | 2009 Aug 1 |
|
Understanding metabolic pathways for skin anti-aging. | 2009 Jul |
|
Painless Acanthamoeba keratitis in a soft contact lens wearer--case report. | 2009 Sep |
|
[Infectious keratitis and cosmetic lenses: a five-case retrospective study]. | 2010 Apr |
|
[Effect of psychotropic drugs on activity of anticonvulsants in maximal electroshock test]. | 2010 Aug |
|
Action potential-enhanced ATP release from taste cells through hemichannels. | 2010 Aug |
|
Antiseptic properties of two calix[4]arenes derivatives on the human coronavirus 229E. | 2010 Dec |
|
[Acanthamoeba keratitis. Report of 3 cases diagnosed in central Tunisia]. | 2010 Feb |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:49:15 GMT 2023
by
admin
on
Fri Dec 15 17:49:15 GMT 2023
|
Record UNII |
023XA5Z50L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m6000
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | Merck Index | ||
|
C018961
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
DTXSID60984372
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
023XA5Z50L
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
211-533-5
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
659-40-5
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
115848
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
023XA5Z50L
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
SUB12021MIG
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
3080571
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
100000080187
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
1939371
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |